NPRRF.US Nipro Corp

Real Estate REIT - Residential USA Stocks
- USD
Market cap
-
P/E
23.5x
P/B
0.72x
ROE
5.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is NPRRF.US undervalued?

Graham number

The Graham number of Nipro Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nipro Corp fundamental analysis

No fundamental analysis for Nipro Corp yet.

Nipro Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nipro Corp

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical Device business develops, manufactures, and sells medical equipment for injection-infusion and dialysis treatment, and products related to diabetes and cell cultures, as well as the sale of artificial organ-related products. The company's Pharmaceutical business provides pharmaceutical combination products, including dual chamber ba…

Full company profile